Literature DB >> 21878171

[The level and clinical significance of Toll-like receptor 4 in children with severe sepsis].

De-hui Chen1, Yi-min Li, Shu-ling Lan, Xiao-an Pan, Lei Zhou, Ming Liang, Hui-min Lu, Fu-xiong Chen.   

Abstract

OBJECTIVE: To study the clinical significance of Toll-like receptor 4 (TLR4) in children with severe sepsis.
METHODS: A prospective control study was performed. All cases were enrolled from pediatric department of the First Affiliated Hospital of Guangzhou Medical College, and they were divided into severe sepsis group (14 patients) who were diagnosed to have severe sepsis or septic shock in intensive care unit (ICU), pneumonia group (10 cases) with diagnosis of bronchial pneumonia, and healthy control group (10 healthy children). Venous blood samples of 2 ml were collected at admission, the level of TLR4 was detected by flow cytometry .At the same time, the changes in serum interleukin (IL-6, IL-10 ) and tumor necrosis factor-α (TNF-α) levels were determined by enzyme linked immunoadsorbent assay (ELISA).
RESULTS: In severe sepsis group, the contents of TLR4 [(71.56±15.32)%], IL-6 [(1.98±1.55) ng/L], IL-10 [(88.20±61.23) ng/L] and TNF-α [(104.08±85.36) ng/L] were significantly higher than those in pneumonia group [(50.07±26.36)%, (0.93±0.16) ng/L, (41.42±7.02) ng/L, (48.96±6.40) ng/L] and healthy control group [(39.43±17.43)%, (0.94±0.43) ng/L,(43.73±22.68) ng/L, ( 49.94± 18.47) ng/L, all P<0.05). But there was no significant difference in the contents of TLR4, IL-6, IL-10 and TNF-α between pneumonia group and healthy control group (all P>0.05).
CONCLUSION: This study suggests that TLR4 might be critically involved in the development of sepsis, and changes in TLR4 expression are parallel with levels of proinflammatory cytokines, including IL-6, TNF-α, and IL-10. The combination of TLR4 and proinflammatory cytokines would serve as the predictive parameters in early diagnosis and severity evaluation of sepsis in children.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21878171

Source DB:  PubMed          Journal:  Zhongguo Wei Zhong Bing Ji Jiu Yi Xue        ISSN: 1003-0603


  1 in total

1.  Pediatric Intensive Care: Immunomodulation With Activated Protein C ex vivo.

Authors:  Hassan O Eliwan; William R G Watson; Irene Regan; Brian Philbin; Fiona M O'Hare; Tammy Strickland; Amanda O'Neill; Michelle O'Rourke; Alfonso Blanco; Martina Healy; Beatrice Nolan; Owen Smith; Eleanor J Molloy
Journal:  Front Pediatr       Date:  2019-09-27       Impact factor: 3.418

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.